AGHC / Aeon Global Health Corp - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

AGHC / Aeon Global Health Corp / Ibex Investors LLC - SC 13G/A Passive Investment

SC 13G/A 1 tm224610d3sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* AEON Global Health Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 00774U107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* AEON Global Health Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* AEON Global Health Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 00774U107 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Aeon Global Health Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 00774U107 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur

AGHC / Aeon Global Health Corp. NT 10-Q - - FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 000-20190 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR For Period Ended: September 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report

Current Report

SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act November 1, 2019 Date of Report (Date of Earliest Event Reported) Aeon Global Health Corp.

Subsidiaries of Registrant.

EXHIBIT 21.1 List of Subsidiary Companies Peachstate Health Management LLC d/b/a AEON Clinical Laboratories Gainesville, Georgia Authentidate, Inc. Berkeley Heights, New Jersey Trac Medical Solutions, Inc. Berkeley Heights, New Jersey ExpressMD Solutions LLC Berkeley Heights, New Jersey

AGHC / Aeon Global Health Corp. 10-K - Annual Report - FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 000-20190 AEON GLOBAL HEALTH

Conversion agreement dated September 25, 2019

Exhibit 10.1 DEBT CONVERSION AGREEMENT This Debt Conversion Agreement (the “Agreement”) is entered into effective as of , 2019 by and between (“Debt Holder”) and Aeon Global Health Corp., a Delaware corporation (the “Company”), with reference to the following facts: WHEREAS, Debt Holder holds promissory notes and other debt totaling $, of which the Company and the Debt Holder desire to convert $ (

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act September 25, 2019 Date of Report (Date of Earliest Event Reported) Aeon Global Health Corp.

AGHC / Aeon Global Health Corp. NT 10-K - - FORM NT 10-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 0-20190 CUSIP Number: 00774U107 ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: June 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transitio

AGHC / Aeon Global Health Corp. 10-Q - Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-

AGHC / Aeon Global Health Corp. NT 10-Q NT 10-Q

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response . . . . . . 2.50 SEC FILE NUMBER 0-20190 CUSIP NUMBER 00774U107 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: Ma

AGHC / Aeon Global Health Corp. / Jones Holly - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

AGHC / Aeon Global Health Corp. / Desai Shawn - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 28, 2019 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

AGHC / Aeon Global Health Corp. / Roshan Hanif A - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No.

AGHC / Aeon Global Health Corp. / Roy Gulzar - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No.

AGHC / Aeon Global Health Corp. / Ali Sohail - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No.

AGHC / Aeon Global Health Corp. FORM 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* AEON Global Health Corp. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 00774U107 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur

AGHC / Aeon Global Health Corp. FORM 10-Q/A (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 23, 2019 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) Close File COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisd

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 16, 2019 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of i

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 19, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

AGHC / Aeon Global Health Corp. FORM S-8

As filed with the Securities and Exchange Commission on December 18, 2018 Registration No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 aghc201812078k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 5, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067

AGHC / Aeon Global Health Corp. FORM DEFA14A

DEFA14A 1 aghc20181206defa14a.htm FORM DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (AMENDMENT NO. 1) Under the Securities Exchange Act of 1934 AEON Global Health Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 00774U107 (CUSIP Number) November 23, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

AGHC / Aeon Global Health Corp. FORM 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:

AGHC / Aeon Global Health Corp. FORM 10-K/A (Annual Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 000-20190

AGHC / Aeon Global Health Corp. FORM DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

2011 Omnibus Equity Incentive Plan, as amended (incorporated by reference herein to Exhibit A to the Company's definitive Proxy Statement dated October 26, 2018).

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

AGHC / Aeon Global Health Corp. FORM PRE 14A

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

8-K 1 aghc201810018k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 26, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-16730

AGHC / Aeon Global Health Corp. FORM 10-K (Annual Report)

10-K 1 aghc2018063010k.htm FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission F

Subsidiaries of Registrant.

EXHIBIT 21.1 List of Subsidiary Companies Peachstate Health Management LLC d/b/a AEON Clinical Laboratories Gainesville, Georgia Authentidate, Inc. Berkeley Heights, New Jersey Trac Medical Solutions, Inc. Berkeley Heights, New Jersey ExpressMD Solutions LLC Berkeley Heights, New Jersey

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 aghc201809138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 7, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-167306

AGHC / Aeon Global Health Corp. / Ali Sohail - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No.

AGHC / Aeon Global Health Corp. / Roy Gulzar - SCHEDULE 13D/A Activist Investment

SC 13D/A 1 roygu20180726sc13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Aeon Global Health Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 00774U 107 (CUSIP Number) Gulzar Roy 2225 Centennial Drive Gainesville, GA 30504 (888) 661-022

AGHC / Aeon Global Health Corp. / Roshan Hanif A - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No.

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 aghc201807238k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): July 19, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (S

Form of Grid Note Issued July 19, 2018 (filed as Exhibit 4.1 to Current Report on Form 8-K filed on July 24, 2018).

Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE FEDERAL OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR HYPOTHECATED IN ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH LAWS AS MAY BE APPLICABLE OR, AN OPINION OF COUNSEL THAT AN EXEMPTION FROM SUCH APPLICABLE LAWS EXIST. AEON GLOBAL HEALTH CORP. SENIOR SECURED GRID NOTE Maximum Principal Amount: $[1,100,000.00.00]

Form of Note Exchange Agreement dated July 19, 2018 (filed as Exhibit 10.2 to Current Report on Form 8-K filed on July 24, 2018).

Exhibit 10.2 NOTE EXCHANGE AGREEMENT THIS NOTE EXCHANGE AGREEMENT (this “Agreement”) is dated as of July 19, 2018, between Aeon Global Health Corp., a Delaware corporation (the “Company”) and the holders identified on the signature pages hereto (each, a “Holder” and collectively, the “Holders”). Recitals WHEREAS, pursuant to the terms and conditions of this Agreement, the Company hereby offers to

Amendment to Amended and Restated Security Agreement dated July 19, 2018 (filed as Exhibit 10.4 to Current Report on Form 8-K filed on July 24, 2018).

Exhibit 10.4 AMENDMENT NO. 2 TO AMENDED AND RESTATED SECURITY AGREEMENT THIS AMENDMENT NO. 2 to the AMENDED AND RESTATED SECURITY AGREEMENT AMENDMENT (this “Agreement”) is made and entered into as of July 19, 2018 by Aeon Global Health Corp. (formerly, Authentidate Holding Corp.), a Delaware corporation (the “Company”) and each of the holders of the secured notes listed on the signature pages here

Consent and Amendment Agreement dated July 19, 2018 (filed as Exhibit 10.3 to Current Report on Form 8-K filed on July 24, 2018).

Exhibit 10.3 CONSENT AND AMENDMENT AGREEMENT This CONSENT AND AMENDMENT AGREEMENT (this “Consent”), dated as of July 19, 2018, is entered into by and among AEON GLOBAL HEALTH CORP., a Delaware corporation (the “Company”) and each of the holders of the Senior Notes (as such term is defined below) set forth on the signature pages hereto. WHEREAS, the Company has issued an aggregate principal amount

Form of Settlement and Restructuring Agreement dated July 19, 2018 (filed as Exhibit 10.1 to Current Report on Form 8-K filed July 24, 2018).

Exhibit 10.1 EACH FORMER MEMBER EXECUTING THIS AGREEMENT IS ADVISED TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS AGREEMENT. BY SIGNING THIS AGREEMENT AND RELEASE, YOU GIVE UP AND WAIVE IMPORTANT LEGAL RIGHTS. SETTLEMENT AND RESTRUCTURING AGREEMENT This Settlement and Restructuring Agreement (the “Agreement”) is made as of the 19th day of July, 2018 (the “Execution Date”) by and among Aeon Globa

Current Report

8-K 1 aghc201806298k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 30, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (S

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 18, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of inco

AGHC / Aeon Global Health Corp. FORM 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-

Form of Restricted Stock Unit Agreement granted March 31, 2018 (filed as Exhibit 10.4 to Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2018).

Exhibit 10.4 AEON GLOBAL HEALTH CORP. NOTICE OF GRANT OF RESTRICTED STOCK UNITS The Participant has been granted an award of Restricted Stock Units (the “Award”) pursuant to the Aeon Global Health Corp. 2011 Omnibus Equity Incentive Plan (the “Plan”), each of which represents the right to receive on the Settlement Date (described below) one (1) share of common stock of Aeon Global Health Corp., pa

AGHC / Aeon Global Health Corp. / Roshan Hanif A - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No.

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 31, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of inc

Form of Amendment to amended and Restated Security Agreement

Exhibit 10.3 AMENDMENT NO. 1 TO AMENDED AND RESTATED SECURITY AGREEMENT THIS AMENDMENT NO. 1 to the AMENDED AND RESTATED SECURITY AGREEMENT AMENDMENT (this “Agreement”) is made and entered into as of March 27, 2018 by Aeon Global Health Corp. (formerly, Authentidate Holding Corp.), a Delaware corporation (the “Company”) and each of the holders of the secured notes listed on the signature pages her

Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 27, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of inc

Form of New Senior Note Issued March 27, 2018 (filed as Exhibit 4.1 to Current Report on Form 8-K filed on March 28, 2018).

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST

Form of Consent and Amendment Agreement

Exhibit 10.2 CONSENT AND AMENDMENT AGREEMENT This CONSENT AND AMENDMENT AGREEMENT (this “Amendment”), dated as of March 27, 2018, is entered into by and among AEON GLOBAL HEALTH CORP. (formerly, Authentidate Holding Corp.), a Delaware corporation (the “Company”) and each of the holders of the Prior Senior Notes (as such term is defined below) listed on the signature pages hereto. WHEREAS, the Comp

Form of Note Exchange Agreement dated March 27, 2018 (filed as Exhibit 10.1 to Current Report on Form 8-K filed March 28, 2018).

Exhibit 10.1 NOTE EXCHANGE AGREEMENT THIS NOTE EXCHANGE AGREEMENT (this “Agreement”) is dated as of March 27, 2018, between Aeon Global Health Corp., a Delaware corporation (the “Company”) and the holder identified on the signature pages hereto (each, a “Holder” and collectively, the “Holders”). Recitals WHEREAS, pursuant to the terms and conditions of this Agreement, the Company hereby offers to

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (AMENDMENT NO. ) Under the Securities Exchange Act of 1934 AEON Global Health Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 00774U107 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

Authentidate Announces Name Change to AEON Global Health Corp to Reflect Broader Healthcare Focus and Innovative Solutions New Trading Symbol “AGHC” Effective February 1, 2018

ex104052.htm Exhibit 99.1 Authentidate Announces Name Change to AEON Global Health Corp to Reflect Broader Healthcare Focus and Innovative Solutions New Trading Symbol ?AGHC? Effective February 1, 2018 For Immediate Release: Gainesville, GA ? January 31, 2018 ? Authentidate Holding Corp. (OTCQB: ADAT), announced today that it has completed its previously announced corporate name change to Aeon Glo

Current Report

aghc201801318k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 31, 2018 AEON GLOBAL HEALTH CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or othe

Certificate of Amendment to Certificate of Incorporation (filed as Exhibit 3.1 to Current Report on Form 8-K as filed with the Securities and Exchange Commission on February 1, 2018).

ex104051.htm EXHIBIT 3.1 CERTIFICATE OF AMENDMENT OF THE AMENDED CERTIFICATE OF INCORPORATION OF AUTHENTIDATE HOLDING CORP. Authentidate Holding Corp. (hereinafter called the ?Corporation?), organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), does hereby certify as follows: FIRST: That at a meeting of the Board of Dire

Consulting Agreement between the Company and Armando Moncada, M.D. (*)

EXHIBIT 10.1 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the “Agreement”) is made, entered and effective as of January 4th, 2018 (the “Effective Date”), by and between Authentidate Holding Corp. d/b/a Aeon Global Health, a Delaware corporation (“AEON”), and Dr. Armando Moncada, MD, a Georgia resident (“MONCADA” and/or “Consultant”). RECITALS: A. AEON owns and operates Peachstate Health Managem

Form of Note (*)

EXHIBIT 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

ADAT / AuthentiDate Holding Corp. FORM 10-Q (Quarterly Report)

10-Q 1 adat2017123110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis

Current Report

adat201801098k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 4, 2018 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or oth

Aeon Global Health Names

ex102843.htm Exhibit 99.1 Aeon Global Health Names Armando Moncada, MD, FCAP as Chief Medical Officer of its Anatomic Pathology Business Company Also Announces Agreement to Acquire Certain IP Assets of PCG Molecular, LLC For Immediate Release: Gainesville, GA, January 10, 2018: Aeon Global Health (ADAT: OTCQB), a growth-oriented provider of personalized, clinically actionable medical informatics a

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 8, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

ADAT / AuthentiDate Holding Corp. FORM S-8

As filed with the Securities and Exchange Commission on December 7, 2017 Registration No.

Letter of Resignation of Richard Hersperger.

Exhibit 17.2 Richard G. Hersperger 12209 Linshan Drive, North Huntingdon PA 15642 September 12, 2017 Aeon Global Health Authentidate Holding Corporation 2225 Centennial Drive Gainesville,GA 30504 Re: Notice to the Board of Immediate Resignation from the Authentidate Holding Corporation / Aeon Global Health, Board of Directors To All Directors and Officers of Authentidate Holding Corporation / Aeon

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 7, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or ot

ADAT / AuthentiDate Holding Corp. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-20190 AUTHENTI

AuthentiDate Holding DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

AuthentiDate Holding DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Subsidiaries of Registrant.

EXHIBIT 21.1 List of Subsidiary Companies PeachState Health Management LLC d/b/a AEON Clinical Laboratories Gainesville, Georgia Authentidate, Inc. Berkeley Heights, New Jersey Trac Medical Solutions, Inc. Berkeley Heights, New Jersey ExpressMD Solutions LLC Berkeley Heights, New Jersey

Form of Restricted Stock Unit Agreement issued June 2, 2017 (filed as Exhibit 10.27 to the Annual Report on Form 10-K on October 13, 2017).

EXHIBIT 10.27 AUTHENTIDATE HOLDING CORP. NOTICE OF GRANT OF RESTRICTED STOCK UNITS The Participant has been granted an award of Restricted Stock Units (the “Award”) pursuant to the Authentidate Holding Corp. 2011 Omnibus Equity Incentive Plan (the “Plan”), each of which represents the right to receive on the Settlement Date (described below) one (1) share of common stock of Authentidate Holding Co

ADAT / AuthentiDate Holding Corp. FORM 10-K (Annual Report)

10-K 1 v47660510k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2017 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 000-20190 AUTHE

Shareholder Director Nominations

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 26, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction

AuthentiDate Holding NT 10-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 0-20190 CUSIP Number: 052666302 x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR o Form N-CSR For the Period Ended: June 30, 2017 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transitio

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 8, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

Employment Letter entered into on September 8, 2017 with Michael J. Poelking (filed as Exhibit 10.2 to Current Report on form 8-K filed September 14, 2017).

Exhibit 10.2 Authentidate Holding Corp. 2225 Centennial Drive Gainesville, GA 30504 September 6, 2017 Michael J. Poelking Re: Offer of Employment by Authentidate Holding Corp. Dear Michael: I am very pleased to confirm our offer to you of employment with Authentidate Holding Corp., a Delaware corporation (the ?Company?), for the position of Chief Financial Officer and Treasurer, reporting to the C

Employment Letter entered into on September 8, 2017 with David C. Goldberg (filed as Exhibit 10.1 to Current Report on form 8-K filed September 14, 2017).

Exhibit 10.1 Authentidate Holding Corp. 2225 Centennial Drive Gainesville, GA 30504 September 6, 2017 David C. Goldberg Re: Offer of Employment by Authentidate Holding Corp. Dear David: I am very pleased to confirm our offer to you of employment with Authentidate Holding Corp., a Delaware corporation (the ?Company?), for the position of Chief Operating Officer, reporting to the Company?s Chief Exe

Emails dated September 7, 2017

Exhibit 17.1 From: Joseph Hudak Sent: Thursday, September 7, 2017 4:27 PM To: Goldstein, Michael; Richard Hersperger Subject: Resignation of Richard G. Hersperger Dear Mr. Goldstein: I represent Richard G. Hersperger. Please accept this email as Mr. Hersperger?s resignation from the Board of Directors of Authentidate Holding Corporation / Aeon Global Health, effective immediately. Mr. Hersperger i

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 7, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

Letter of Resignation of Richard Hersperger.

Exhibit 17.2 Richard G. Hersperger 12209 Linshan Drive, North Huntingdon PA 15642 September 12, 2017 Aeon Global Health Authentidate Holding Corporation 2225 Centennial Drive Gainesville,GA 30504 Re: Notice to the Board of Immediate Resignation from the Authentidate Holding Corporation / Aeon Global Health, Board of Directors To All Directors and Officers of Authentidate Holding Corporation / Aeon

ADAT / AuthentiDate Holding Corp. FORM 10-Q (Quarterly Report)

10-Q 1 v47156510q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission Fil

ADAT / AuthentiDate Holding Corp. / Roy Gulzar - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

ADAT / AuthentiDate Holding Corp. / Ali Sohail - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

ADAT / AuthentiDate Holding Corp. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-20190 AUTHENTID

ADAT / AuthentiDate Holding Corp. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-20190 AUTHENTI

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities

8-K 1 v4685738k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 1, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State

AuthentiDate Holding FORM 12B-25

NT 10-Q 1 v467146nt10q.htm FORM 12B-25 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 0-20190 CUSIP Number: 052666302 o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR o Form N-CSR For the Period Ended: March 31, 2017 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tr

April 24, 2017

Exhibit 16.1 April 24, 2017 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated April 24, 2017 of Authentidate Holding Corp. and are in agreement with the statements contained therein as it regards our firm. We have no basis to agree or disagree with other statements of the registrant contained in Item 4.01. Sinc

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): April 18, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of i

AuthentiDate Holding FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 000-20190 AUTHENTIDATE HOLDING CORP. (Exact Nam

AuthentiDate Holding 10-Q/A (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-

List of Subsidiary Companies

EXHIBIT 21 List of Subsidiary Companies PeachState Health Management LLC d/b/a AEON Clinical Laboratories Gainesville, Georgia Authentidate, Inc. Berkeley Heights, New Jersey Trac Medical Solutions, Inc. Berkeley Heights, New Jersey ExpressMD Solutions LLC Berkeley Heights, New Jersey

Specimen of Series E Convertible Preferred Stock Certificate (filed as Exhibit 4.37 to Annual Report on Form 10-K filed on April 5, 2017).

Exhibit 4.37 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE OR EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFER

Certificate of Designations, Preferences and Rights and Number of Shares of Series E Convertible Preferred Stock (filed as Exhibit 3.1 to current report on Form 8-K filed on March 24, 2017).

Exhibit 3.1 AUTHENTIDATE HOLDING CORP. CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS AND NUMBER OF SHARES OF SERIES E CONVERTIBLE PREFERRED STOCK Pursuant to Section 151 of the Delaware General Corporation Law The undersigned President of AUTHENTIDATE HOLDING CORP., a Delaware corporation (the ?Corporation?), hereby certifies that pursuant to authority granted to and vested in the Board of D

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 20, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of i

Form of Exchange Agreement for Series E Preferred Stock dated March 20, 2017 (filed as Exhibit 10.2 to Current Report on Form 8-K filed March 24, 2017).

Exhibit 10.2 EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (this ?Agreement?) is dated as of March 20, 2017, between Authentidate Holding Corp., a Delaware corporation (the ?Company?) and the holder identified on the signature pages hereto (the ?Holder?). Recitals WHEREAS, the Holders beneficially owns and holds 28,000 shares of the Company?s Series B Preferred Stock, par value $0.10 per share; and W

Form of New Note Issued March 20, 2017 (filed as Exhibit 4.1 to Current Report on Form 8-K filed on March 24, 2017).

Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST

Form of Note Exchange Agreement dated March 20, 2017 (filed as Exhibit 10.1 to Current Report on form 8-K filed on March 24, 2017).

Exhibit 10.1 NOTE EXCHANGE AGREEMENT THIS NOTE EXCHANGE AGREEMENT (this ?Agreement?) is dated as of March 20, 2017, between Authentidate Holding Corp., a Delaware corporation (the ?Company?) and the holders identified on the signature pages hereto (each, a ?Holder? and collectively, the ?Holders?). Recitals WHEREAS, pursuant to the terms and conditions of this Agreement, the Company hereby offers

Form of Security Agreement dated March 20, 2017 (filed as Exhibit 10.3 to Current Report on form 8-K filed March 24, 2017).

Exhibit 10.3 AMENDED AND RESTATED SECURITY AGREEMENT THIS AMENDED AND RESTATED SECURITY AGREEMENT (this ?Security Agreement?) is made and entered into as of March 20, 2017 by Authentidate Holding Corp., a Delaware corporation (the ?Company?) and the parties signatory hereto (each, a ?Secured Party? and collectively, the ?Secured Parties?). This Security Agreement is being executed and delivered by

ADAT / AuthentiDate Holding Corp. / Roshan Hanif A - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

Separation Agreement with William Henry (filed as Exhibit 10.1 to the Current Report on Form 8-K filed on March 3, 2017).

Exhibit 10.1 AGREEMENT AND RELEASE CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS AGREEMENT AND RELEASE. BY SIGNING THIS AGREEMENT AND RELEASE, YOU GIVE UP AND WAIVE IMPORTANT LEGAL RIGHTS. This is an agreement and release (the ?Agreement?) between Authentidate Holding Corp., its stockholders (solely in their capacity as stockholders of Authentidate Holding Corp.), its subsidiaries, affiliates, divi

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 27, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

8-K 1 v4601338k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 17, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (

PROMISSORY NOTE

Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE FEDERAL OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR HYPOTHECATED IN ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH LAWS AS MAY BE APPLICABLE OR, AN OPINION OF COUNSEL THAT AN EXEMPTION FROM SUCH APPLICABLE LAWS EXIST. PROMISSORY NOTE Principal Amount: $250,000.00 Issuance Date: January 31, 2017 Maturity Date: M

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 31, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 18, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or o

January 18, 2017

Exhibit 17.2 January 18, 2017 Michael A. Goldstein Authentidate holding Corp Corporate Counsel Becker & Poliakoff 45 Broadway, 8th Floor New York, NY 10006 Mr. Goldstein, I strongly disagree with the content of the 8k disclosure. The disclosure contains misrepresentation of the facts and makes unsubstantiated allegation, such as ?my positions were more aligned with those of Mr. Hersperger rather t

Ron Oklewicz 11927 Triple Crown Rd • Reston, VA 20191 • 703.402.2389

Exhibit 17.1 Ron Oklewicz 11927 Triple Crown Rd ? Reston, VA 20191 ? 703.402.2389 January 11, 2017 Mr. Sonny Roshan Chairman and CEO Aeon Global Health 2225 Centennial Drive Gainesville, GA 30504 Dear Chairman Roshan, I joined the Board of Directors of Authentidate effective January 2016 with enthusiasm for the possibilities that the announced merger of Authentidate and Aeon Clinical presented. I

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 11, 2017 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

ADAT / AuthentiDate Holding Corp. / Roshan Hanif A - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.

JOINT FILING AGREEMENT

EXHIBIT A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.

ADAT / AuthentiDate Holding Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 27) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666302 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 15, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

Amendment No. 2 dated as of December 15, 2016 to Amended and Restated Merger Agreement (filed as Exhibit 2.1 to Current Report on Form 8-K filed on December 21, 2016).

Exhibit 2.1 AMENDMENT NO. 2 TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER This Amendment No. 2 to Amended and Restated Agreement and Plan of Merger, dated as of December 14, 2016 (this ?Amendment?), by and among Authentidate Holding Corp., a Delaware corporation (?Buyer?), and PeachState Health Management, d/b/a AEON Clinical Laboratories, a Georgia limited liability company (?Target?). Cap

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 7, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

Amended and Restated By-laws (filed as Exhibit 3.1 to Current Report on Form 8-K, dated December 13, 2016).

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF AUTHENTIDATE HOLDING CORP. (Amended and Restated as of December 7, 2016) aRTICLE I - OFFICES 1.1 Registered Office. The corporation shall have and maintain in the State of Delaware a registered office which may, but need not be, the same as its place of business. 1.2 Other Offices. The corporation may also have offices and places of business at such plac

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1 to Form 8-K filed February 1, 2016) CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 26, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS On January 27, 2016, Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories (?AEON?) merged into a newly formed acquisition subsidiary of Authentidate Holding Corp. (?AHC? or ?ADAT?) pursuant to a definitive Amended and Restated Agreement and Plan of Merger dated January 26, 2016, as amended on May 31, 2016 (colle

ADAT / AuthentiDate Holding Corp. / PVAM Perlus Microcap Fund, L.P. - SCHEDULE 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1) AUTHENTIDATE HOLDING CORP. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 052666302 (CUSIP Number) November 14, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs

AuthentiDate Holding FORM 12B-25

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 0-20190 CUSIP Number: 052666302 ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form N-SAR ? Form N-CSR For the Period Ended: September 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Tran

ADAT / AuthentiDate Holding Corp. / PVAM Perlus Microcap Fund, L.P. - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 AUTHENTIDATE HOLDING CORP. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 052666302 (CUSIP Number) October 14, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc

ADAT / AuthentiDate Holding Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 26) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666302 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

JOINT FILING AGREEMENT

EXHIBIT A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.

Trade Date

EXHIBIT B TRANSACTIONS The following table sets forth all transactions with respect to shares of common stock effected during the past sixty days by the Reporting Persons or on behalf of the Reporting Persons in respect of the shares, inclusive of any transactions effected through the close of trading on October 17, 2016.

AuthentiDate Holding FORM 12B-25

FORM 12b-25 SEC FILE NUMBER 000-20190 NOTIFICATION OF LATE FILING CUSIP NUMBER 025666302 (Check One): x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

List of Subsidiary Companies

Exhibit 21 List of Subsidiary Companies PeachState Health Management, d/b/a AEON Clinical Laboratories, Gainesville, Georgia Authentidate, Inc. Berkeley Heights, New Jersey Trac Medical Solutions, Inc. Berkeley Heights, New Jersey ExpressMD Solutions LLC Berkeley Heights, New Jersey

AGHC / Aeon Global Health Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-20190 AUTHENTIDATE

ENGAGEMENT LETTER

EX-10.60 2 v449225ex10-60.htm EXHIBIT 10.60 Exhibit 10.60 ENGAGEMENT LETTER This consulting Agreement (“Agreement”) is entered into as of the 2nd day of March, 2016 (“Effective Date”), by and among Aeon Clinical Laboratories (“Aeon”), with address at 2225 Centennial Drive, Gainesville, GA 30504, and Windham Brannon, P.C. (Windham Brannon” or “the Firm”). Background Aeon and Windham Brannon wish to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KT

10-KT 1 v44922510kt.htm 10-KT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KT (Mark One) ¨ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 x TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from January 1, 2015 to June 30, 2015 Commission File No: 000-20190 AUTHENTIDATE HOL

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 7, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of in

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): July 11, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdicti

2011 Omnibus Equity Incentive Plan amended July 11, 2016 (filed as Exhibit 10.1 to Current Report on Form 8-K filed July 13, 2016).

EX-10.1 2 d225778dex101.htm EX-10.1 Exhibit 10.1 AUTHENTIDATE HOLDING CORP. 2011 OMNIBUS EQUITY INCENTIVE PLAN Authentidate Holding Corp. (the “Company”), a Delaware corporation, hereby establishes and adopts the following 2011 Omnibus Equity Incentive Plan (this “Plan”). 1. PURPOSE OF THIS PLAN The purpose of this Plan is to advance the interests of the Company’s stockholders by enhancing the Com

AuthentiDate Holding DEF 14A

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Amendment No. 1 dated as of May 31, 2016 to Amended and Restated Merger Agreement, dated as of January 26, 2016 (filed as Exhibit 2.1 to Current Report on Form 8-K filed on June 6, 2016).

EX-2.1 2 d198509dex21.htm EX-2.1 Exhibit 2.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER This Amendment No. 1 to Amended and Restated Agreement and Plan of Merger, dated as of May 31, 2016 (this “Amendment”), by and among Authentidate Holding Corp., a Delaware corporation (“Buyer”), RMS Merger Sub LLC, a Georgia limited liability company (“Merger Sub”), and PeachState Heal

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 31, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdictio

AMENDMENT NO. 1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER

EX-2.1 Exhibit 2.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER This Amendment No. 1 to Amended and Restated Agreement and Plan of Merger, dated as of May 31, 2016 (this ?Amendment?), by and among Authentidate Holding Corp., a Delaware corporation (?Buyer?), RMS Merger Sub LLC, a Georgia limited liability company (?Merger Sub?), and PeachState Health Management, d/b/a AEON

AuthentiDate Holding FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 31, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdictio

AuthentiDate Holding ESP

CORRESP JOSEPH WALSH 212.704.6030 telephone 212.704.5919 facsimile [email protected] TROUTMAN SANDERS LLP Attorneys at Law The Chrysler Building 405 Lexington Avenue New York, New York 10174-0700 212.704.6000 telephone troutmansanders.com June 6, 2016 VIA EDGAR AND FEDERAL EXPRESS Matthew Crispino Attorney Advisor United States Securities and Exchange Commission Division of Corporat

AuthentiDate Holding NT 10Q

NT 10Q SEC FILE NUMBER 000-20190 CUSIP NUMBER 025666302 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

Authentidate Holding PRE 14A

PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Authentidate Announces AEON’s audited results for the year ended December 31, 2015 2015 Revenue of $34.85 Million Net Income of $13.75 Million EBITDA of $16.36 Million

EX-99.1 Exhibit 99.1 Authentidate Announces AEON?s audited results for the year ended December 31, 2015 2015 Revenue of $34.85 Million Net Income of $13.75 Million EBITDA of $16.36 Million BERKELEY HEIGHTS, N.J., April 25, 2016 (GLOBE NEWSWIRE) ? Authentidate Holding Corp. (NASDAQ;BBT; ADAT), one of the fastest growing clinical labs in North America through its wholly owned subsidiary, Aeon Clinic

Financial Statements and Exhibits, Other Events

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): April 25, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

Authentidate Announces AEON’s audited results for the year ended December 31, 2015 2015 Revenue of $34.85 Million Net Income of $13.75 Million EBITDA of $16.36 Million

EX-99.1 Exhibit 99.1 Authentidate Announces AEON?s audited results for the year ended December 31, 2015 2015 Revenue of $34.85 Million Net Income of $13.75 Million EBITDA of $16.36 Million BERKELEY HEIGHTS, N.J., April 25, 2016 (GLOBE NEWSWIRE) ? Authentidate Holding Corp. (NASDAQ;BBT; ADAT), one of the fastest growing clinical labs in North America through its wholly owned subsidiary, Aeon Clinic

Authentidate Holding 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): April 25, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

Authentidate Holding FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): April 8, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdicti

Authentidate Holding 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 15, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

Aeon Global Health is an innovative, high-growth healthcare company that enables personalized medicine. Main offerings include genetic testing, toxicology testing and tele-health technology products Well positioned to secure a meaningful portion of a

EX-99.1 2 d136033dex991.htm EX-99.1 Company Overview Bill Henry, COO Aeon Global Health / Authentidate March 2016 Exhibit 99.1 This presentation contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this presentation, the words “believe,” “anticipate,” “think,” “intend,” “plan,” “will be,” “ex

Aeon Global Health is an innovative, high-growth healthcare company that enables personalized medicine. Main offerings include genetic testing, toxicology testing and tele-health technology products Well positioned to secure a meaningful portion of a

EX-99.1 Company Overview Bill Henry, COO Aeon Global Health / Authentidate March 2016 Exhibit 99.1 This presentation contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this presentation, the words ?believe,? ?anticipate,? ?think,? ?intend,? ?plan,? ?will be,? ?expect,? and similar expressio

Authentidate Holding 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 15, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

EX-24.1

POWER OF ATTORNEY Know all by these presents that the undersigned, Thomas P. Leahey, hereby constitutes and appoints each of Michael A. Goldstein and Sarah E. Klein, or any one of them acting singly, as his true and lawful attorneys-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or a director of Authentidate Holding Corp. (th

Authentidate Holding FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 1, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdict

Tom Leahey, Appointed Interim Chief Financial Officer of Authentidate Experienced Public Company Executive Joins Senior Management

EX-99.1 Exhibit 99.1 Berkeley Heights, NJ March 4, 2016 Tom Leahey, Appointed Interim Chief Financial Officer of Authentidate Experienced Public Company Executive Joins Senior Management Authentidate Holding Corp. (OTCQB: ADAT), one of the fastest growing clinical labs in North America through its wholly owned subsidiary Aeon Clinical Laboratories, and a provider of secure web-based revenue cycle

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 22, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other juris

AUTHENTIDATE ANNOUNCES SECOND QUARTER FINANCIAL RESULTS Combination with AEON Clinical Laboratories Leverages Technology and Specialized Lab Testing Capabilities to Offer Innovative Healthcare Solutions

EX-99.1 Exhibit 99.1 FOR RELEASE: Thursday, February 22, 2016 Berkeley Heights, NJ February 22, 2016 AUTHENTIDATE ANNOUNCES SECOND QUARTER FINANCIAL RESULTS Combination with AEON Clinical Laboratories Leverages Technology and Specialized Lab Testing Capabilities to Offer Innovative Healthcare Solutions Authentidate Holding Corp. (OTCQB: ADAT), a provider of secure web-based revenue cycle managemen

AGHC / Aeon Global Health Corp. 10-Q - Quarterly Report - FORM 10-Q

Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

AuthentiDate Holding NT 10-Q

NT 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 0-20190 CUSIP Number: 052666302 ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form N-SAR ? Form N-CSR For the Period Ended: December 31, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q

AuthentiDate Holding SC 14F1

SC 14F1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14F-1 Information Statement Pursuant to Section 14(f) of the Securities Exchange Act of 1934 and Rule 14f-1 Promulgated Thereunder AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) Delaware 0-20190 14-1673067 (State or Other Jurisdiction of Incorporation or Organization) (Commis

ADAT / AuthentiDate Holding Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 25) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666302 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

Form of Registration Rights Agreement by and among Authentidate Holding Corp. and the AEON Members, dated as of January 26, 2016 (filed as Exhibit 10.1 to Current Report on Form 8-K filed February 1, 2016).

EX-10.1 Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of January [ ], 2016, by and among Authentidate Holding Corp., a Delaware corporation (the ?Company?), and the persons whose names appear on the signature page annexed hereto (collectively the ?Investors?) constituting the former members of Peachstate Health Management, LLC d/b/a AEON Clin

PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS December 31, 2014 and 2013 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS REPOR

EX-99.3 Exhibit 99.3 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS December 31, 2014 and 2013 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 CONSOLIDATED BALANCE SHEETS 2 CONSOLIDATED STATEMENTS OF OPERATIONS 3 CONSOL

Authentidate and AEON Clinical Laboratories Execute Amendment to Merger Agreement and Schedule Closing

EX-99.1 Exhibit 99.1 FOR RELEASE: Wednesday, January 27, 2016 Berkeley Heights, NJ Gainesville, GA Authentidate and AEON Clinical Laboratories Execute Amendment to Merger Agreement and Schedule Closing Authentidate Holding Corp. (NASDAQ: ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories, today announced that they have entered into an amendment to their agreement and plan

PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2015 and 2014 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS CONS

EX-99.4 9 d123401dex994.htm EX-99.4 Exhibit 99.4 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2015 and 2014 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS CONSOLIDATED BALANCE SHEET 1 CONSOLIDATED STATEMENTS OF OPERATIONS 2 CONSOLIDATED STATEMENT OF CHANGES IN

Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company Authentidate Common Stock to Commence Trading on the OTCQB Market Under the Ticker Symbol “ADAT” on January 29, 2016 Sonny Roshan to serve as

EX-99.2 7 d123401dex992.htm EX-99.2 Exhibit 99.2 FOR RELEASE: Thursday, January 28, 2016 Berkeley Heights, NJ Gainesville, GA Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company Authentidate Common Stock to Commence Trading on the OTCQB Market Under the Ticker Symbol “ADAT” on January 29, 2016 Sonny Roshan to serve as Chairman of the Board;

REGISTRATION RIGHTS AGREEMENT

EX-10.1 Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of January [ ], 2016, by and among Authentidate Holding Corp., a Delaware corporation (the ?Company?), and the persons whose names appear on the signature page annexed hereto (collectively the ?Investors?) constituting the former members of Peachstate Health Management, LLC d/b/a AEON Clin

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

8-K 1 d123401d8k.htm 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 26, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE

Authentidate and AEON Clinical Laboratories Execute Amendment to Merger Agreement and Schedule Closing

EX-99.1 Exhibit 99.1 FOR RELEASE: Wednesday, January 27, 2016 Berkeley Heights, NJ Gainesville, GA Authentidate and AEON Clinical Laboratories Execute Amendment to Merger Agreement and Schedule Closing Authentidate Holding Corp. (NASDAQ: ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories, today announced that they have entered into an amendment to their agreement and plan

AuthentiDate Holding 8-K

8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

FIRST LEASE AMENDMENT

EX-10.2 Exhibit 10.2 STATE OF GEORGIA COUNTY OF HALL FIRST LEASE AMENDMENT THIS FIRST LEASE AMENDMENT (the ?Amendment?) is made and entered into as of the 20th day of January, 2016, by and between CENTENNIAL PROPERTIES OF GEORGIA, LLC, a Georgia limited liability company (?Landlord?), and PEACHSTATE HEALTH MANAGEMENT, LLC, a Georgia limited liability company (?Tenant?). WHEREAS the parties entered

AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER BY AND AMONG AUTHENTIDATE HOLDING CORP, RMS MERGER SUB LLC, PEACHSTATE HEALTH MANAGEMENT, LLC d/b/a AEON CLINICAL LABORATORIES Dated as of January 26, 2016 TABLE OF CONTENTS Page ARTICLE 1 TRANSACTION

EX-2.1 Exhibit 2.1 EXECUTION COPY AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER BY AND AMONG AUTHENTIDATE HOLDING CORP, RMS MERGER SUB LLC, AND PEACHSTATE HEALTH MANAGEMENT, LLC d/b/a AEON CLINICAL LABORATORIES Dated as of January 26, 2016 TABLE OF CONTENTS Page ARTICLE 1 TRANSACTIONS AND TERMS OF TRANSACTION 3 1.1 THE MERGER 3 1.2 CLOSING 3 1.3 EFFECTIVE TIME 3 1.4 EFFECT OF THE MERGER 4 1.5

Lease Agreement dated as of March 1, 2014, as amended January 20, 2016, between Centennial Properties of Georgia, LLC and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories (filed as Exhibit 10.2 to Current Report on Form 8-K filed February 1, 2016).

EX-10.2 Exhibit 10.2 STATE OF GEORGIA COUNTY OF HALL FIRST LEASE AMENDMENT THIS FIRST LEASE AMENDMENT (the ?Amendment?) is made and entered into as of the 20th day of January, 2016, by and between CENTENNIAL PROPERTIES OF GEORGIA, LLC, a Georgia limited liability company (?Landlord?), and PEACHSTATE HEALTH MANAGEMENT, LLC, a Georgia limited liability company (?Tenant?). WHEREAS the parties entered

Amended and Restated Agreement and Plan of Merger dated as of January 26, 2016, by and among, Authentidate Holding Corp., RMS Merger Sub, LLC, and Peachstate Health Management LLC, d/b/a AEON Clinical Laboratories (filed as Exhibit 2.1 to Current Report on Form 8-K filed on February 1, 2016).

EX-2.1 Exhibit 2.1 EXECUTION COPY AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER BY AND AMONG AUTHENTIDATE HOLDING CORP, RMS MERGER SUB LLC, AND PEACHSTATE HEALTH MANAGEMENT, LLC d/b/a AEON CLINICAL LABORATORIES Dated as of January 26, 2016 TABLE OF CONTENTS Page ARTICLE 1 TRANSACTIONS AND TERMS OF TRANSACTION 3 1.1 THE MERGER 3 1.2 CLOSING 3 1.3 EFFECTIVE TIME 3 1.4 EFFECT OF THE MERGER 4 1.5

PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS December 31, 2014 and 2013 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS REPOR

EX-99.3 8 d123401dex993.htm EX-99.3 Exhibit 99.3 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS December 31, 2014 and 2013 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 1 CONSOLIDATED BALANCE SHEETS 2 CONSOLIDATED STATE

Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company Authentidate Common Stock to Commence Trading on the OTCQB Market Under the Ticker Symbol “ADAT” on January 29, 2016 Sonny Roshan to serve as

EX-99.2 7 d123401dex992.htm EX-99.2 Exhibit 99.2 FOR RELEASE: Thursday, January 28, 2016 Berkeley Heights, NJ Gainesville, GA Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company Authentidate Common Stock to Commence Trading on the OTCQB Market Under the Ticker Symbol “ADAT” on January 29, 2016 Sonny Roshan to serve as Chairman of the Board;

PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2015 and 2014 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS CONS

EX-99.4 9 d123401dex994.htm EX-99.4 Exhibit 99.4 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2015 and 2014 PEACH STATE HEALTH MANAGEMENT, LLC AND SUBSIDIARY d/b/a AEON CLINICAL LABORATORIES TABLE OF CONTENTS CONSOLIDATED BALANCE SHEET 1 CONSOLIDATED STATEMENTS OF OPERATIONS 2 CONSOLIDATED STATEMENT OF CHANGES IN

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 20, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdi

Authentidate Holding Corp. Announces Reverse Stock Split Common stock will begin trading on a split-adjusted basis on January 25, 2016 Stockholders also Approve Amendment to Certificate of Incorporation to Preserve Tax Benefits

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Berkeley Heights, NJ January 22, 2016 Authentidate Holding Corp. Announces Reverse Stock Split Common stock will begin trading on a split-adjusted basis on January 25, 2016 Stockholders also Approve Amendment to Certificate of Incorporation to Preserve Tax Benefits Berkeley Heights, N.J. ? January 22, 2016 ? Authentidate Holding Corp. (Nasdaq: ADAT) today

JOINT FILING AGREEMENT

EX-99.A 2 exa.htm EXHIBIT A Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.001 per share, of Authentidate Holding Corp., a Delaware corporation, is being filed

Certificate of Amendment to Certificate of Incorporation (filed as Exhibit 3.2 to Current Report on Form 8-K as filed with the Securities and Exchange Commission on January 22, 2016).

EX-3.2 Exhibit 3.2 CERTIFICATE OF AMENDMENT OF THE AMENDED CERTIFICATE OF INCORPORATION OF AUTHENTIDATE HOLDING CORP. Authentidate Holding Corp. (hereinafter called the ?Corporation?), organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), does hereby certify as follows: FIRST: The name of the Corporation is Authentidate

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

SC 13D/A 1 adatscd13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 24) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry C

Certificate of Amendment to Certificate of Incorporation (filed as Exhibit 3.1 to Current Report on Form 8-K as filed with the Securities and Exchange Commission on January 22, 2016).

EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED CERTIFICATE OF INCORPORATION OF AUTHENTIDATE HOLDING CORP. AUTHENTIDATE HOLDING CORP., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), does hereby certify: FIRST: The name of the Corporation is Authentidate Holding Corp. (the ?Corporation?). S

Form of Lockup Agreement (filed as Exhibit 10.2 to Current Report on Form 8-K filed January 21, 2016).

EX-10.2 Exhibit 10.2 January 2016 Authentidate Holding Corp. Connell Corporate Center 300 Connell Drive, 5th Floor Berkeley Heights, NJ 07922 Attn: Ian C. Bonnet, Chief Executive Officer Dear Mr. Bonnet: Re: Lockup Agreement of [AEON MEMBER] The undersigned is a current member of Peachstate Health Management LLC, (d/b/a AEON Clinical Laboratories), a limited liability company formed under the laws

Amendment Agreement dated January 15, 2016 (filed as Exhibit 10.1 to Current Report on Form 8-K filed January 21, 2016).

EX-10.1 Exhibit 10.1 NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this ?Amendment?), dated as of January 15, 2016 (the ?Effective Date?), is entered into by and among AUTHENTIDATE HOLDING CORP., a Delaware corporation (the ?Company? or the ?Borrower?) and MKA 79, LLC the holder (the ?Holder?) of the Note (as such term is defined below). WHEREAS, the Company has issued to the Holder a pr

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 14, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdi

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 8, 2016 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdi

AuthentiDate Holding DEFA14A

DEFA14A 1 d118889ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as

AMENDMENT NO. 1 TO SECURITY AGREEMENT

EX-10.3 Exhibit 10.3 AMENDMENT NO. 1 TO SECURITY AGREEMENT THIS SECURITY AGREEMENT AMENDMENT NO 1. (this “Agreement”) is made and entered into as of December 11, 2015 by Authentidate Holding Corp., a Delaware corporation (the “Company”) and MKA 79, LLC (“MKA”) and VER 83, LLC (“VER” and together the “Secured Parties”). W I T N E S S E T H: WHEREAS, MKA and the Company are parties to a Security Agr

AUTHENTIDATE HOLDING CORP. 9% SENIOR SUBORDINATED SECURED CONVERTIBLE NOTE

EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE

STOCKHOLDER VOTING AGREEMENT

EX-10.4 9 d76442dex104.htm EX-10.4 Exhibit 10.4 STOCKHOLDER VOTING AGREEMENT THIS STOCKHOLDER VOTING AGREEMENT (this “Agreement”) is made and entered into as of December , 2015, by and among Peachstate Health Management LLC, a limited liability company formed under the laws of the state of Georgia (“Target”), Authentidate Holding Corp., a Delaware corporation (“Buyer”), and the undersigned stockho

Form of Warrant issuable to Lazarus Investment Partners, LLLP (filed as Exhibit 4.4 to Current Report on Form 8-K filed on December 17, 2015).

EX-4.4 Exhibit 4.4 NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE HEREUNDER HAVE BEEN REGISTERED UNDER THE SECURITIES ACT (AS DEFINED BELOW), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR (B) AN OPINION OF COUNSEL, IN A GENERAL

NOTE EXCHANGE AGREEMENT

Exhibit B NOTE EXCHANGE AGREEMENT THIS NOTE EXCHANGE AGREEMENT (this "Agreement") is dated as of December 15, 2015, between Authentidate Holding Corp.

PROMISSORY NOTE

EX-99.C 4 exc.htm EXHIBIT C Exhibit C THIS NOTE HAS NOT BEEN REGISTERED UNDER THE FEDERAL OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR HYPOTHECATED IN ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH LAWS AS MAY BE APPLICABLE OR, AN OPINION OF COUNSEL THAT AN EXEMPTION FROM SUCH APPLICABLE LAWS EXIST. PROMISSORY NOTE Principal Amount: $532,811 Issuance Date: December 1

NOTE EXCHANGE AGREEMENT

EX-10.2 Exhibit 10.2 NOTE EXCHANGE AGREEMENT THIS NOTE EXCHANGE AGREEMENT (this ?Agreement?) is dated as of December 15, 2015, between Authentidate Holding Corp., a Delaware corporation with its address at Authentidate Holding Corp., Connell Corporate Center, 300 Connell Drive, Berkeley Heights, New Jersey 07922 (the ?Company?) and Lazarus Investment Partners LLLP (the ?Holder?), with its address

AuthentiDate Holding 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 11, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdictio

NOTE EXCHANGE AGREEMENT

EX-10.1 Exhibit 10.1 NOTE EXCHANGE AGREEMENT THIS NOTE EXCHANGE AGREEMENT (this ?Agreement?) is dated as of December 11, 2015, between Authentidate Holding Corp., a Delaware corporation with its address at Authentidate Holding Corp., Connell Corporate Center, 300 Connell Drive, Berkeley Heights, New Jersey 07922 (the ?Company?) and VER 83, LLC (the ?Holder?), with its address as set forth on the s

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 23) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

December 15, 2015

Exhibit E December 15, 2015 Authentidate Holding Corp. Connell Corporate Center 300 Connell Drive, 5th Floor Berkeley Heights, NJ 07922 Attn: Ian C. Bonnet, Chief Executive Officer Dear Mr. Bonnet: Re: Lockup Agreement of Lazarus Investment Partners, LLLP The undersigned is the owner ("Securityholder") of the various securities of Authentidate Holding Corp. (the "Company") as set forth on Schedule

JOINT FILING AGREEMENT

Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.

PROMISSORY NOTE Principal Amount: $532,811 Issuance Date: December 15, 2015 Maturity Date: December 15, 2016

EX-4.3 Exhibit 4.3 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE FEDERAL OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR HYPOTHECATED IN ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH LAWS AS MAY BE APPLICABLE OR, AN OPINION OF COUNSEL THAT AN EXEMPTION FROM SUCH APPLICABLE LAWS EXIST. PROMISSORY NOTE Principal Amount: $532,811 Issuance Date: December 15, 2015 Maturity Da

STOCKHOLDER VOTING AGREEMENT

Exhibit F STOCKHOLDER VOTING AGREEMENT THIS STOCKHOLDER VOTING AGREEMENT (this "Agreement") is made and entered into as of December 15, 2015, by and among Peachstate Health Management LLC, a limited liability company formed under the laws of the state of Georgia ("Target"), Authentidate Holding Corp.

Form of Warrant issuable to VER 83, LLC (filed as Exhibit 4.2 to Current Report on Form 8-K filed on December 17, 2015).

EX-4.2 Exhibit 4.2 NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE HEREUNDER HAVE BEEN REGISTERED UNDER THE SECURITIES ACT (AS DEFINED BELOW), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR (B) AN OPINION OF COUNSEL, IN A GENERAL

AUTHENTIDATE HOLDING CORP. COMMON STOCK PURCHASE WARRANT

Exhibit D NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE HEREUNDER HAVE BEEN REGISTERED UNDER THE SECURITIES ACT (AS DEFINED BELOW), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT (II) UNLESS SOLD OR TRANSFERRED TO A "QUALIFIED INSTITUTIONAL BUYER" WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT OR (III) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.

AuthentiDate Holding DEF 14A

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 24, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

NOTE AMENDMENT AGREEMENT

Exhibit B NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this "Amendment"), dated as of November 24, 2015 (the "Effective Date"), is entered into by and among AUTHENTIDATE HOLDING CORP.

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 22) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

JOINT FILING AGREEMENT

EX-99.A 2 exa.htm EXHIBIT A Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.001 per share, of Authentidate Holding Corp., a Delaware corporation, is being filed

AuthentiDate Holding PRE 14A

PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Authentidate Holding Corp. and AEON Clinical Laboratories Announce Execution of Definitive Merger Agreement

EX-99.1 Exhibit 99.1 FOR RELEASE: Thursday, November 19, 2015 Berkeley Heights, NJ Gainesville, GA November 19, 2015 Authentidate Holding Corp. and AEON Clinical Laboratories Announce Execution of Definitive Merger Agreement Authentidate Holding Corp. (NASDAQ: ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories today announced that they have entered into a definitive merge

AGREEMENT AND PLAN OF MERGER BY AND AMONG AUTHENTIDATE HOLDING CORP, RMS MERGER SUB LLC, PEACHSTATE HEALTH MANAGEMENT, LLC d/b/a AEON CLINICAL LABORATORIES Dated as of November 18, 2015 TABLE OF CONTENTS Page ARTICLE 1 TRANSACTIONS AND TERMS OF TRANS

EX-2.1 2 d39628dex21.htm EX-2.1 Exhibit 2.1 EXECUTION COPY AGREEMENT AND PLAN OF MERGER BY AND AMONG AUTHENTIDATE HOLDING CORP, RMS MERGER SUB LLC, AND PEACHSTATE HEALTH MANAGEMENT, LLC d/b/a AEON CLINICAL LABORATORIES Dated as of November 18, 2015 TABLE OF CONTENTS Page ARTICLE 1 TRANSACTIONS AND TERMS OF TRANSACTION 2 1.1 THE MERGER 2 1.2 CLOSING 2 1.3 EFFECTIVE TIME 3 1.4 EFFECT OF THE MERGER 3

AuthentiDate Holding FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 18, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisd

Authentidate Holding Corp. and AEON Clinical Laboratories Announce Execution of Definitive Merger Agreement

EX-99.1 Exhibit 99.1 FOR RELEASE: Thursday, November 19, 2015 Berkeley Heights, NJ Gainesville, GA November 19, 2015 Authentidate Holding Corp. and AEON Clinical Laboratories Announce Execution of Definitive Merger Agreement Authentidate Holding Corp. (NASDAQ: ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories today announced that they have entered into a definitive merge

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 18, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction of

AGREEMENT AND PLAN OF MERGER BY AND AMONG AUTHENTIDATE HOLDING CORP, RMS MERGER SUB LLC, PEACHSTATE HEALTH MANAGEMENT, LLC d/b/a AEON CLINICAL LABORATORIES Dated as of November 18, 2015 TABLE OF CONTENTS Page ARTICLE 1 TRANSACTIONS AND TERMS OF TRANS

EX-2.1 Exhibit 2.1 EXECUTION COPY AGREEMENT AND PLAN OF MERGER BY AND AMONG AUTHENTIDATE HOLDING CORP, RMS MERGER SUB LLC, AND PEACHSTATE HEALTH MANAGEMENT, LLC d/b/a AEON CLINICAL LABORATORIES Dated as of November 18, 2015 TABLE OF CONTENTS Page ARTICLE 1 TRANSACTIONS AND TERMS OF TRANSACTION 2 1.1 THE MERGER 2 1.2 CLOSING 2 1.3 EFFECTIVE TIME 3 1.4 EFFECT OF THE MERGER 3 1.5 ARTICLES OF ORGANIZA

Authentidate Holding Form SC 13D/A (Acquisition of More Than 5% of Shares)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 21) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 21) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

JOINT FILING AGREEMENT

Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.

AUTHENTIDATE ANNOUNCES FIRST QUARTER FINANCIAL RESULTS Proposed Combination with AEON Clinical Laboratories Progresses

EX-99.1 Exhibit 99.1 FOR RELEASE: Friday, November 13, 2015 Berkeley Heights, NJ November 13, 2015 AUTHENTIDATE ANNOUNCES FIRST QUARTER FINANCIAL RESULTS Proposed Combination with AEON Clinical Laboratories Progresses Authentidate Holding Corp. (Nasdaq: ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, tod

Form of Warrant issued October 28, 2015 (filed as Exhibit 4.7 to Quarterly Report on Form 10-Q filed on November 13, 2015).

Exhibit 4.7 NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE HEREUNDER HAVE BEEN REGISTERED UNDER THE SECURITIES ACT (AS DEFINED BELOW), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCE

NOTE AMENDMENT AGREEMENT

Exhibit 10.7 NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this ?Amendment?), dated as of October 30, 2015 (the ?Effective Date?), is entered into by and among AUTHENTIDATE HOLDING CORP., a Delaware corporation (the ?Company?) and Lazarus Investment Partners LLLP, the holder (the ?Holder?) of the Prior Note (as such term is defined below). WHEREAS, the Company has issued to the Holder a

AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT Authentidate Holding Corp. and certain of the Purchasers to the Securities Purchase Agreement dated as of May 29, 2015

Exhibit 10.9 AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT Authentidate Holding Corp. and certain of the Purchasers to the Securities Purchase Agreement dated as of May 29, 2015 This Amendment No. 2 to the Securities Purchase Agreement and Registration Rights Agreement is effective as of the 25th day of September, 2015 (the ?Second Amendment Agreement?), and is

NOTE PURCHASE AGREEMENT

Exhibit 10.8 NOTE PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of October 28, 2015, among Authentidate Holding Corp., a Delaware corporation (the ?Company?), and each of the purchasers identified on the signature pages hereto (each, a ?Purchaser? and collectively, the ?Purchasers?). BACKGROUND WHEREAS, subject to the terms and conditions set forth in this Ag

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): November 13, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction o

NOTE AMENDMENT AGREEMENT

Exhibit 10.6 NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this ?Amendment?), dated as of October 30, 2015 (the ?Effective Date?), is entered into by and among AUTHENTIDATE HOLDING CORP., a Delaware corporation (the ?Company?) and VER 83, LLC the holder (the ?Holder?) of the Prior Note (as such term is defined below). WHEREAS, the Company has issued to the Holder a promissory note in the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 0-201

PROMISSORY NOTE Principal Amount: $450,000.00 Issuance Date: October 28, 2015 Maturity Date: October 28, 2016

Exhibit 4.6 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE FEDERAL OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR HYPOTHECATED IN ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH LAWS AS MAY BE APPLICABLE OR, AN OPINION OF COUNSEL THAT AN EXEMPTION FROM SUCH APPLICABLE LAWS EXIST. PROMISSORY NOTE Principal Amount: $450,000.00 Issuance Date: October 28, 2015 Maturity Date: O

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 20) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

JOINT FILING AGREEMENT

Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 d43245d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 28, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (St

JOINT FILING AGREEMENT

EX-99.A 2 exa.htm EXHIBIT A Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.001 per share, of Authentidate Holding Corp., a Delaware corporation, is being filed

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

SC 13D/A 1 adatscd13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 19) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry C

NOTE AMENDMENT AGREEMENT

Exhibit B NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this "Amendment"), dated as of October 30, 2015 (the "Effective Date"), is entered into by and among AUTHENTIDATE HOLDING CORP.

AuthentiDate Holding FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 23, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdi

NOTE AMENDMENT AGREEMENT

Exhibit B NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this "Amendment"), dated as of October 23, 2015 (the "Effective Date"), is entered into by and among AUTHENTIDATE HOLDING CORP.

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 18) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

JOINT FILING AGREEMENT

Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.

AuthentiDate Holding 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 16, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdiction

JOINT FILING AGREEMENT

EX-99.A 2 exa.htm EXHIBIT A Exhibit A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock, par value $0.001 per share, of Authentidate Holding Corp., a Delaware corporation, is being filed

AGHC / Aeon Global Health Corp. / Lazarus Management Co LLC - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 17) Under the Securities Exchange Act of 1934 Authentidate Holding Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 052666104 (CUSIP Nubmer) Adam D. Averbach, Esq. c/o Lazarus Management Company LLC 3200 Cherry Creek South Drive, Suite 670 Denver, CO 802

NOTE AMENDMENT AGREEMENT

Exhibit B NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this "Amendment"), dated as of October 16, 2015 (the "Effective Date"), is entered into by and among AUTHENTIDATE HOLDING CORP.

NOTE AMENDMENT AGREEMENT

Exhibit B NOTE AMENDMENT AGREEMENT This NOTE AMENDMENT AGREEMENT (this "Amendment"), dated as of October 9, 2015 (the "Effective Date"), is entered into by and among AUTHENTIDATE HOLDING CORP.

AMENDMENT NO. 2 TO LEASE

Exhibit 10.56 AMENDMENT NO. 2 TO LEASE This Amendment No. 2 to Lease (this ?Amendment?) dated as of September 15, 2015, is made between THE CONNELL COMPANY, a New Jersey corporation (?Landlord?), and AUTHENTIDATE HOLDING CORP., a Delaware corporation (?Tenant?). WHEREAS, Landlord and Tenant are parties to a lease dated as of July 5, 2005, which was amended by Amendment No. 1 to Lease dated as of F

Form of Warrant issued June 8, 2015 (filed as Exhibit 4.28 to Annual Report on Form 10-K for the fiscal year ended June 30, 2015).

Exhibit 4.28 NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE HEREUNDER HAVE BEEN REGISTERED UNDER THE SECURITIES ACT (AS DEFINED BELOW), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACC

SECURITY AGREEMENT

Exhibit 10.45 SECURITY AGREEMENT THIS SECURITY AGREEMENT (this ?Agreement?) is made and entered into as of May 29, 2015 by Authentidate Holding Corp., a Delaware corporation (the ?Company?) and the holders of the Company?s Senior Secured Convertible Debentures (the ?Debentures?) issued from time to time under the Purchase Agreement (defined below) (each, a ?Secured Party? and together, the ?Secure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-20190 AUTHENTID

AuthentiDate Holding 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 13, 2015 AUTHENTIDATE HOLDING CORP. (Exact name of registrant as specified in its charter) COMMISSION FILE NUMBER: 0-20190 DELAWARE 14-1673067 (State or other jurisdictio

AUTHENTIDATE ANNOUNCES FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS Company Provides Update on Proposed Transaction with AEON Clinical Laboratories

EX-99.1 Exhibit 99.1 FOR RELEASE: Tuesday, October 13, 2015 Berkeley Heights, NJ October 13, 2015 AUTHENTIDATE ANNOUNCES FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS Company Provides Update on Proposed Transaction with AEON Clinical Laboratories Authentidate Holding Corp. (Nasdaq: ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for